Humboldt
Venture capitalNew York · Pre-Seed–Series A · 4 people tracked
Also known as HUMBOLDT CAPITAL, LLC
Find your way into Humboldt
363 people in our graph share verified history with the Humboldt team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Exclusive synthetic biology investor focused on companies replacing industrial inputs with biology-based alternatives, led by a UCSF-trained PhD cell biologist offering deep research expertise and global Latin America–Europe reach.
Source: firm website, verified Sep 1, 2026.
Team · 4 people
from curated & public directories
What they invest in
from 16 of 19 portfolio companiesBiotech ×14AI & Machine Learning ×5Healthtech ×5Medical Devices ×5Deep Tech ×3FoodTech ×3Climate Tech ×2New Materials ×2
HQs:United States×11
Investments · 19 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12018 · 24 dated
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Board seatSebastian Bernales· per SEC Form D
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesInCube Ventures+5 more
HealthtechSan Leandro, US
Zachary Sun(Executive Officer, Director)Michael Nemzek(Executive Officer, Director)Corinna Chen(Director)
Board seatFrancisco Dopazo· per SEC Form D · $17.6M raise · filed Sep 2023
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalOlive Tree CapitalService Provider Capital
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Lin-Arlow(Executive Officer, Director)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)in
BoardYanniv Dorone(Director)
Co-investorsCarbon SiliconDauntless VenturesFifty YearsMetaplanetY CombinatorFall Line Capital+2 more
Co-investorsAgFunderAngel Collective Opportunity FundArgonautic VenturesFifty YearsGermin8 VenturesHorizons Ventures+3 more
Cellineobio develops cell engineering and bioprocess technology platforms.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)inNabiha Saklayen(Executive Officer, Director)inMatthias Wagner(Executive Officer, Director)in
Co-investors8VCCota CapitalFelicis VenturesHAWKTAILKhosla VenturesThe Engine Ventures
Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.
AI & Machine LearningBiotechConsumerSan Diego, US
Joshua Britton(Founder)in
Co-investorsGS FuturesMaterial ImpactBreakout VenturesKdT VenturesSandbox IndustriesACVC Partners+8 more
Endpoint Health develops precision medicine tools and targeted therapies for patients with critical illnesses like sepsis and ARDS, leveraging big data and AI to personalize treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Jose, US
Jason Springs(Co-Founder, CEO)Diego Rey(Co-Founder, CSO)Leonardo Teixeira(Co-Founder, COO)Jeff Osborn(Co-Founder, CTO)
Co-investorsWireframe Ventures
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsB3 HoldingOctave Ventures LlcOCV PartnersOMX VenturesShumway Capital
Finless Foods develops cell-cultivated seafood alternatives, starting with Pacific bluefin tuna, aimed at consumers seeking sustainable options that reduce pressure on wild fish stocks.
BiotechClimate TechFoodTech
Brandon Chen(Co-Founder & CEO)inBrian Wyrwas(Co-Founder & CSO)inMichael Selden(Co-Founder & Advisor)in
Co-investorsAt One VenturesAurum Venture PartnersBabel VenturesBlue Horizon CorporationBlue Revolution Investments G.P.Draper Associates+9 more
GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling.
AI & Machine LearningBiotechMedical DevicesCambridge, US
George Church(Co-Founder & Scientific Advisor)Parastoo Khoshakhlagh(Chief Executive Officer & Co-Founder)inAlex Ng(Chief Innovation Officer & Co-Founder)in
Co-investorsAndreessen HorowitzGlobal BrainMedical Excellence Capital
Geltor uses a proprietary biodesign and precision fermentation platform to create and commercially produce novel protein ingredients, including collagens, for beauty and personal care formulators.
BiotechFoodTechNew MaterialsWellness & Fitness
Alexander Lorestani(Founder)inNick Ouzounov(Co-founder)in
Co-investorsAgronomicsAlwyn CapitalArgonautic VenturesBaruch Future VenturesBlue Horizon CorporationCavallo Ventures+12 more
Dutch cultivated meat company that grew pork from pluripotent stem cells; wound down operations in December 2025.
Co-investorsBackedHAWKTAILFuture Positive Capital
Automates complex biological protocols in a compact cartridge-based system for genomic sequencing
BiotechSan Francisco, US
Ferran Galindo(Director)inFoteini Christodoulou(Director)
BoardAlejandro Tocigl(Executive Officer, Director)
Co-investorsCota CapitalID345Kayyak VenturesNazcaSun Mountain CapitalOS Fund
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)
BoardDavid Bowman(Director)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Blue Ledge CapitalJoyance Partners+6 more
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Director)inMichael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)in
BoardKiersten Stead(Director)inThomas Grotkjaer(Director)
Co-investorsDCVC (Data Collective)Hemisphere Ventures LLCWireframe Ventures8VCAgFunderDCVC Bio+3 more
Phage Lab develops solutions to address bacterial outbreaks using a One Health approach, bringing together around 100 scientists and professionals from multiple disciplines in animal health and microbiology.
AgTechAI & Machine LearningBiotech
Pablo Cifuentes Palma(Founder)inHans Pieringer(Founder)in
Co-investorsCollaborative FundInvexor Venture PartnersNazcaThe Yield Lab LatamKaszek Ventures
Chilean food technology company that uses machine learning to reformulate animal-based foods such as mayonnaise, milk and burgers from plants.
Karim Pichara(Founder)in
Co-investorsSustainable Food VenturesThe CraftoryCleveland AvenueMAYA Capital VenturesTrousdale Ventures
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactKdT Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesMetagenomi · za.investing.com · Aug 11, 2026
Finless Foods · blog.seedstage.ai · Apr 30, 2026
Phage Lab · latamrepublic.com · Apr 10, 2026
GC Therapeutics · nasdaqprivatemarket.com · Apr 3, 2026
Geltor · geltor.com · Oct 13, 2025
Ansa Biotechnologies · drugdiscoverynews.com · Oct 9, 2025
Frequently asked questions
- What stage does Humboldt invest at?
- Humboldt invests at the Pre-Seed, Seed, Series A stages.
- What is Humboldt's typical check size?
- Humboldt typically writes checks of $100K – $5M.
- What sectors does Humboldt focus on?
- Humboldt focuses on AgTech, AI & Machine Learning, Biotech, FoodTech, Hardware, Healthtech, New Materials.
- Where is Humboldt located?
- Humboldt is headquartered in New York, US.
- Does Humboldt lead rounds?
- Humboldt typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamVentures #7 w/ Francisco Dopazo - General Partner @ Humboldt Fund | BIOS
BIOS · Francisco Dopazo
Co-investors · 5
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Causal is a financial planning and analysis platform that enables finance teams to move beyond traditional spreadsheet-based planning by integrating data from multiple sources and providing dynamic forecasting, budgeting, and scenario planning capabilities.
Tencent is a Chinese technology company operating consumer products such as Tencent Games and Weixin/WeChat, business services including Tencent Cloud, and technology research units like Tencent Media Lab and Ethereal Lab.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
Firms observed investing alongside Humboldt, from public investor directories. Shared companies are the overlap with Humboldt's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Rockies Venture Club is an angel investor network of 100+ active members focused on Seed to Series A opportunities, offering due diligence, syndication nationwide, and educational programming for investors and entrepreneurs.
MPG Fund is an early-stage venture investor backing technology startups.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
Nordic Science Investments (NSI) is an early-stage investor that turns university research and scientific discoveries into startups, partnering with founders across the New Nordics.